Brief: Entera Bio Announces Q1 2023 Financial Results
05/05/2023 21:21
May 5 (Reuters) - Entera Bio Ltd 5DT.F :
* ENTERA BIO ANNOUNCES Q1 2023 FINANCIAL RESULTS AND
CORPORATE
UPDATES
* ENTERA BIO LTD - EXPECTS THAT ITS EXISTING CASH RESOURCES
ARE
SUFFICIENT TO MEET ITS PROJECTED OPERATING REQUIREMENTS INTO Q3
OF 2024
* ENTERA BIO LTD - QTRLY LOSS PER SHARE $0.08
Source text for Eikon: ID:nGNX9v2gMR
Further company coverage: 5DT.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement